Compare Stocks → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:IBBNYSEARCA:IHINYSEARCA:VHTNYSEARCA:XBI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$133.42+0.6%$133.13$111.83▼$141.16$7.37B0.841.78 million shs981,442 shsIHIiShares U.S. Medical Devices ETF$55.86+1.3%$56.69$43.96▼$59.14$5.28B0.831.16 million shs686,790 shsVHTVanguard Health Care ETF$261.99+0.9%$262.28$222.27▼$271.53$17.59B0.61185,673 shs114,170 shsXBISPDR S&P Biotech ETF$89.02-0.1%$91.25$63.80▼$103.52$6.79B1.1111.58 million shs7.55 million shsThese 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF-0.52%+2.39%-0.06%-1.24%+1.52%IHIiShares U.S. Medical Devices ETF-1.45%+0.24%-3.40%-3.13%-0.61%VHTVanguard Health Care ETF-0.50%+0.96%-0.78%-1.40%+6.26%XBISPDR S&P Biotech ETF-1.46%+2.01%-1.43%-0.12%+3.72%Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AIHIiShares U.S. Medical Devices ETFN/AN/AN/AN/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBBiShares Biotechnology ETF0.00N/A$157.4317.99% UpsideIHIiShares U.S. Medical Devices ETF0.00N/A$62.9812.74% UpsideVHTVanguard Health Care ETF0.00N/A$287.909.89% UpsideXBISPDR S&P Biotech ETF0.00N/A$119.2733.98% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AIHIiShares U.S. Medical Devices ETFN/AN/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBBiShares Biotechnology ETFN/AN/A0.00∞N/AN/AN/AN/AN/AIHIiShares U.S. Medical Devices ETFN/AN/A35.18∞N/AN/AN/AN/AN/AVHTVanguard Health Care ETFN/AN/A23.22∞N/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/A11.47∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIBBiShares Biotechnology ETF$0.400.30%N/AN/AN/AIHIiShares U.S. Medical Devices ETF$0.240.43%N/AN/AN/AVHTVanguard Health Care ETF$3.301.26%N/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/ALatest VHT, IBB, XBI, and IHI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/20/2024IBBiShares Biotechnology ETFQuarterly$0.12603/21/20243/22/20243/27/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBBiShares Biotechnology ETF62.45%IHIiShares U.S. Medical Devices ETFN/AVHTVanguard Health Care ETFN/AXBISPDR S&P Biotech ETFN/AInsider OwnershipCompanyInsider OwnershipIBBiShares Biotechnology ETFN/AIHIiShares U.S. Medical Devices ETFN/AVHTVanguard Health Care ETFN/AXBISPDR S&P Biotech ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableIBBiShares Biotechnology ETFN/A55.25 millionN/AOptionableIHIiShares U.S. Medical Devices ETFN/A94.50 millionN/ANot OptionableVHTVanguard Health Care ETFN/A67.14 millionN/ANot OptionableXBISPDR S&P Biotech ETFN/A76.22 millionN/ANot OptionableVHT, IBB, XBI, and IHI HeadlinesSourceHeadlineSPDR S&P Biotech ETF Sees Unusually Large Options Volume (NYSEARCA:XBI)americanbankingnews.com - May 2 at 4:26 AMStock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocksmsn.com - April 30 at 1:46 PMXBI June 7th Options Begin Tradingnasdaq.com - April 28 at 6:40 PMIs SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?zacks.com - April 23 at 7:21 AMSome Bubbles Are Starting To Popseekingalpha.com - April 21 at 6:37 PMNovartis Looks To Get Back On Track With Q1 Earningsseekingalpha.com - April 20 at 12:02 AM2 Top Biotech Buyout Candidatesmsn.com - March 28 at 3:15 PM2 Top Biotech Buyout Candidateszacks.com - March 28 at 2:56 PM3 Biotech Stocks to Buy on the Dip: March 2024investorplace.com - March 27 at 1:07 PMShould You Invest in the SPDR S&P Biotech ETF (XBI)?zacks.com - March 25 at 7:20 AM3 Biotech ETFs Overdue for a Bounceinvestorplace.com - March 19 at 2:45 PMBiotech stock fundings headed for best quarter in 3 years, Jefferies saysbiopharmadive.com - March 11 at 2:06 PMBiotech Stocks Are on a Tear. They Could Keep Climbing.msn.com - February 29 at 8:45 AMHeard on the Street Recap: Zooming Upwsj.com - February 28 at 8:30 PMHere's why SPDR Biotech ETF (XBI) stock price is flyinginvezz.com - February 28 at 1:05 AMIs SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?zacks.com - February 22 at 7:21 AMWhere Are Biotech ETFs Headed After Q4 Earnings?zacks.com - February 14 at 5:51 PMSpdr S&P Biotech Etfreuters.com - February 13 at 5:23 PMXBI ETF Stock Price Historyinvesting.com - February 10 at 7:09 PMSPDR S&P Biotech ETF (XBI)finance.yahoo.com - February 3 at 8:10 AMHow To Buy Hot And Promising — But Uncertain — Biotech Stocksmsn.com - January 8 at 1:12 PM5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Mondaybenzinga.com - January 8 at 8:11 AMLate M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conferencereuters.com - January 5 at 7:27 AMNovavax in 2024: What to expect?msn.com - December 28 at 3:37 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsSeagate Technology Warns Cloud Demand is Heating Up April 30, 2024 10:10 AMView Seagate Technology Warns Cloud Demand is Heating Up Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?April 16, 2024 6:15 AMView Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?All Headlines Company DescriptionsiShares Biotechnology ETFNASDAQ:IBBiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.iShares U.S. Medical Devices ETFNYSEARCA:IHIThe iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.Vanguard Health Care ETFNYSEARCA:VHTVanguard Health Care ETF seeks to track the investment performance of the MSCI US Investable Market Health Care 25/50 Index, a benchmark of large-, mid-, and small-cap United States stocks in the health care sector, as classified under the Global Industry Classification Standard (GICS). This GICS sector is made up of two main industry groups. The first group includes companies that manufacture health care equipment and supplies or provide health care related services (such as distributors of health care products, providers of basic health care services, and owners and operators of health care facilities and organizations). The second group includes companies primarily involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. The Vanguard Group, Inc., through its Quantitative Equity Group, serves as the investment advisor of the Fund.SPDR S&P Biotech ETFNYSEARCA:XBISPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.